Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6078498, 6 pages
https://doi.org/10.1155/2017/6078498
Research Article

Mortality and Cardiovascular Complications in Older Complex Chronic Patients with Type 2 Diabetes

1Department of Research, ICS Terres de l’Ebre, University Institute in Primary Care Research Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain
2EAP-Camarles-Aldea-Ampolla, Catalonian Health Institute, SAP Terres de l’Ebre, Health Department, Generalitat de Catalunya, CAP Ampolla, 43895 Tortosa, Spain
3EAP Tortosa 1-Est, Catalonian Health Institute, SAP Terres de l’Ebre, Health Department, Generalitat de Catalunya, CAP Temple, 43500 Tortosa, Spain
4EAP Tortosa-2-Oest, Catalonian Health Institute, SAP Terres de l’Ebre, Health Department, Generalitat de Catalunya, CAP Xerta, Barcelona, 43592 Catalonia, Spain
5UUDD Tortosa-Terres de l’Ebre, CAP Temple, EAP Tortosa Est, Institut Català de la Salut, 43500 Tortosa, Spain
6EAP-Camarles-Aldea-Ampolla, Catalonian Health Institute, SAP Terres de l’Ebre, Health Department, Generalitat de Catalunya, CAP Camarles, 43894 Tortosa, Spain
7EAP-Alcanar-St Carles de la Rápita, Catalonian Health Institute, SAP Terres de l’Ebre, Health Department, Generalitat de Catalunya, CAP St Carles de la Rápita, 43894 Tortosa, Spain

Correspondence should be addressed to J. L. Clua-Espuny; tac.tacneg@sci.erbe.aulclj

Received 3 April 2017; Accepted 10 July 2017; Published 10 August 2017

Academic Editor: Charbel Abi Khalil

Copyright © 2017 J. L. Clua-Espuny et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Aims/Introduction. Determining the prevalence of diabetes and its cardiovascular complications and all-cause mortality in older chronic complex patients. Materials and Methods. We carried out a multicenter retrospective study and included a randomized sample of 932 CCP people. We assessed the prevalence of diabetes according to World Health Organization criteria. Data included demographics and functional, comorbidity, cognitive, and social assessment. Results. The prevalence of diabetes was 53% and average age years. There were no significant differences in the survival of CCP patients with or without DM, with or without ischaemic cardiopathy, and with or without peripheral vascular disease. The prognostic factors of all-cause mortality in patients with DM were age ≥ 80 years [HR 1.47, 95% CI 1.02–2.13, ], presence of heart failure [HR 1.73, 95% CI 1.25–2.38, ], Charlson score [HR 1.20, 95% CI 1.06–1.36, ], presence of cognitive impairment [HR 1.73, 95% CI 1.24–2.40, ], and no treatment with statins [HR 1.49, 95% CI 1.08–2.04, ]. Conclusions. We found high prevalence of DM among CCP patients and the relative importance of traditional risk factors seemed to wane with advancing age. Recommendations may include relaxing treatment goals, providing family/patient education, and enhanced communication strategies.